Herbalife Ltd. HLF announced third quarter financial results Tuesday, with EPS of $1.45 per share versus $1.51 per share estimates.
Revenue also missed expectations by 4.55 percent, or $60 million.
Following the downbeat results, analysts at Pivotal Research Group cut the target price on Herbalife from $110 to $75, but remain with a Buy rating.
Timothy Ramey finds the company missed on key metrics and offered weaker-than-expected guidance, consequently "We see the valuation of Herbalife as less attractive than it was before the 3Q – but still quite compelling."
Ramey highlights that distributor counts were weaker than expected, which brings into question future growth.
“We value HLF on a P/E basis with a “tainted” valuation of 13.3x 2015 EPS a low value for a company that has consistently grown top-line and EPS in double-digit rates, but perhaps reasonable for the no-growth outlook for 2015.”
Shares of Herbalife recently traded at $44.63, down 20 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.